Pain
Project Twenty21 publishes first findings on chronic pain
Data from over 900 medical cannabis patients, living with chronic pain, has been published this week.
Search
24 results for “twenty21”
News
Project Twenty21 prices to remain the same next month as talks ongoing
Prescription prices won’t change as planned in March amid ongoing discussions with partners.
News
MyAccess Clinics rejoins Project Twenty21 to help build real-world data
MyAccess Clinics (MAC) will now be taking on new patients through Project Twenty21.
News
Drug Science delays Project Twenty21 pricing changes in response to patient concerns
New pricing models announced this month will not come into effect until March.
Health
Project Twenty21 announces changes to landmark medical cannabis study
Pricing changes are due to come into effect from February.
Advocacy
Two years on Project Twenty21 helps almost 2,000 patients access medical cannabis
David Horn, the project’s development lead, reflects on its progress so far.
Industry
Wales’ first medical cannabis clinic welcomes patients on Project Twenty21
Cannabis Clinic Cardiff is focused on treating patients with a range of mental health conditions.
Pain
“Chronic pain patients feel let down” – UK’s first digital pain clinic joins Project Twenty21
The UK’s first fully digital pain clinic is giving millions of patients another option
Health
Project Twenty21 finds medical cannabis dramatically improves quality of life
The first findings from the UK’s largest medical cannabis patient study show quality of life improved by more than 50%
News
My experience as a medical cannabis prescriber on Project Twenty21
In the second of a two-part series, Cannabis Health speaks to Dr Rebecca Moore about her experience as a prescriber on Drug Science’s Project Twenty21. Project Twenty21 is a landmark […]
News
What’s it like to be a patient on Project Twenty21?
Drug Science’s Project Twenty21 is a landmark scheme that seeks to widen access to medicinal cannabis and build Europe’s largest body of evidence for its efficacy. In a two-part […]
News
Professor Mike Barnes joins Project Twenty21
The drug advisory committee, Drug Science, has appointed Professor Mike Barnes as clinical lead for its flagship medical cannabis programme, Project Twenty21. The project aims to widen access to medical […]
News
UK Survey Finds Majority of Medical Cannabis Patients Report Improved Mental Health Symptoms
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
Science
Lancet Review of Medical Cannabis in Mental Health – What the Study Shows
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
Industry
Podcast | From Anecdote to Evidence: Using Data for Advanced Access with Releaf & Dr Anne Katrin Schlag
In a special edition of the Business of Cannabis Podcast, we go from anecdote to evidence with Dr Anne Katrin Schlag, Head of Research at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf.
Industry
UK cannabis clinics Leva and Zerenia merge to expand patient care
The partnership aims to improve treatment options available to patients with chronic pain.
News
Drug Science T21 study to continue for fifth year with new partners
The new partners will help to secure the future of the project.
Industry
Khiron calls for wider NHS reimbursement of cannabis-based medicines following recent success
Khiron Europe is confident that its efforts in collecting evidence will allow the UK to follow in the footsteps of Germany’s thriving medical cannabis market.
Patients
Why are so many patients still accessing medical cannabis illegally in the UK?
Only a tiny fraction of UK medical cannabis patients are accessing the legal market. Why is that and what do we do about it?
Case Studies
‘A second chance at life’: researchers make the case for medicinal cannabis in chronic pain
A new case study highlights the potential of cannabis for improving quality of life in patients with neuropathic pain.
Mental health
How cannabis may have helped Prince Harry’s mental health – the science and expert opinion
Prince Harry comments are not only relatable to many, but are backed up by a growing body of research.
Industry
Grow Pharma joins T21 to help patients access more affordable medicinal cannabis
The addition of Grow Pharma allows T21 to add more cannabis-based medicines its formulary.
News
UK patient registry to continue for fourth year with key changes
Project Twenty21 will continue collecting data for a fourth year with new partners on board.
Medical cannabis
Can cannabis help your mental health? Everything you need to know
We look beyond the stigma to explore the role cannabis could play in treating some of the most common mental health conditions.